Quinolinic and kainic acids can enhance calcitonin gene-related peptide-like immunoreactivity in striatal neurons with substance P-like immunoreactivity
- 1 August 1987
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 418 (2) , 392-397
- https://doi.org/10.1016/0006-8993(87)90110-7
Abstract
No abstract availableFunding Information
- Medical Research Foundation (61131004, 61218006, 62121004, 62570025)
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 35 references indexed in Scilit:
- Calcitonin gene-related peptide in the ventral tegmental area: Selective modulation of prefrontal cortical dopamine metabolismNeuroscience Letters, 1987
- Calcitonin gene-related peptide, a peptide present in spinal cord motoneurons, increases the number of acetylcholine receptors in primary cultures of chick embryo myotubesNeuroscience Letters, 1986
- Autoradiographic localization of calcitonin gene-related peptide binding sites in human and rat brainsBrain Research, 1986
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986
- Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptideEuropean Journal of Pharmacology, 1985
- Topographic localization of calcitonin gene-related peptide in the rat brain: An immunohistochemical analysisNeuroscience, 1985
- A mouse neuroblastoma × rat glioma hybrid cell produces immunoreactive substance P-like materialBrain Research, 1981
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- In situ injection of kainic acid: A new method for selectively lesioning neuronal cell bodies while sparing axons of passageJournal of Comparative Neurology, 1978
- Lesion of striatal neurons with kainic acid provides a model for Huntington's choreaNature, 1976